(S)-4′-HPPH O-Glucuronide Formation | (R)-4′-HPPH O-Glucuronide Formation | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S50 | Vmax | Normalized Vmax | CLmax | n | S50 | Vmax | Normalized Vmax | CLmax | n | |||||||||
μM | pmol/min/mg | pmol/min/unit | nl/min/unit | μM | pmol/min/mg | pmol/min/unit | nl/min/unit | |||||||||||
UGT1A1 Supersomes | 81 ± 20 | 14 ± 1 | 1 ± 0 | 6 ± 1 | 1.4 ± 0.1 | 110 ± 27 | 179 ± 25 | 11 ± 2 | 55 ± 4 | 1.6 ± 0.3 | ||||||||
UGT1A9 Supersomes | 25 ± 1 | 38 ± 1 | 4 ± 0 | 91 ± 1 | 1.3 ± 0.0 | 33 ± 4 | 16 ± 1 | 2 ± 0 | 46 ± 3a | 1.0 ± 0.1 | ||||||||
UGT2B15 Supersomes | 91 ± 12 | 504 ± 55 | N.A. | N.A. | 1.7 ± 0.1 | 96 ± 6 | 121 ± 19 | N.A. | N.A. | 2.2 ± 0.1 | ||||||||
UGT1A1b | 48 ± 5 | 9 ± 0 | 9 ± 0 | 23 ± 2 | 1.8 ± 0.2 | 74 ± 12 | 110 ± 5 | 110 ± 5 | 194 ± 20 | 1.6 ± 0.2 | ||||||||
UGT1A1/1A4b | 49 ± 1 | 7 ± 0 | 12 ± 0** | 30 ± 1** | 1.8 ± 0.2 | 70 ± 5 | 86 ± 3 | 138 ± 5** | 250 ± 6** | 1.7 ± 0.2 | ||||||||
UGT1A1/1A6b | 66 ± 2* | 3 ± 0 | 4 ± 0** | 10 ± 1** | 1.7 ± 0.4 | 91 ± 14 | 35 ± 4 | 56 ± 6** | 81 ± 6** | 1.6 ± 0.2 | ||||||||
UGT1A9b | 23 ± 2 | 9 ± 1 | 67 ± 9 | 382 ± 16 | 1.5 ± 0.1 | 56 ± 14 | 3 ± 0 | 22 ± 3 | 56 ± 7 | 1.5 ± 0.4 | ||||||||
UGT1A4/1A9b | 22 ± 2 | 12 ± 2 | 52 ± 8 | 296 ± 28† | 1.7 ± 0.1 | 41 ± 6 | 4 ± 1 | 15 ± 2† | 50 ± 11 | 1.6 ± 0.2 | ||||||||
UGT1A6/1A9b | 35 ± 5†† | 15 ± 1 | 50 ± 4† | 192 ± 18†† | 1.5 ± 0.1 | 54 ± 8 | 4 ± 1 | 14 ± 2† | 35 ± 2† | 1.5 ± 0.2 |
N.A., not available.
↵* P < 0.005.
↵** P < 0.01, compared with single-expression system of UGT1A1 in HEK293 cells.
↵† P < 0.005.
↵†† P < 0.01, compared with single-expression system of UGT1A9 in HEK293 cells.
↵ a The intrinsic clearance (Vmax/Km) was calculated, because the kinetics was fitted to Michaelis-Menten equation.
↵ b HEK293 expression systems that were established in our previous studies (Fujiwara et al., 2007a,b).